[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Aspergillosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 80 pages | ID: A39850C824A8EN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Aspergillosis Drug pipeline report- 2020 is an annual R&D review of Aspergillosis pipeline candidates. The report presents the current status of all major Aspergillosis therapeutic compounds. Detailed insights into Aspergillosis pipeline development, current status, companies, drug profiles and Aspergillosis preclinical and clinical trials are included.

2020 Aspergillosis Pipeline Market Insights
Aspergillosis disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Aspergillosis therapies, pipeline by phase and others are included.

Aspergillosis pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Aspergillosis Therapeutic Drug candidates
Both active and inactive Aspergillosis pipeline drug candidates are included in the report

Aspergillosis Clinical Trials and preclinical Studies
Aspergillosis In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Aspergillosis pipeline market developments
Aspergillosis Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Aspergillosis pipeline companies in active development
The report analyzes Aspergillosis pipeline of the below companies-

Acea Biotech Inc, Amplyx Pharmaceuticals Inc, Astellas Pharma Inc, Basilea Pharmaceutica Ltd, Biosergen AS, Cidara Therapeutics Inc, F2G Ltd, iCo Therapeutics Inc., Matinas BioPharma, Mayne Pharma Group Ltd, Merck & Co Inc, Molecular Express Inc, Novabiotics Ltd, Pulmatrix Inc, Pulmocide Ltd, Scynexis Inc, Sealife PHARMA GMBH, Shaanxi Synthetic Pharmaceutical Co Ltd, Viamet Pharmaceuticals Inc, Vical Inc, Visterra Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
21 Companies investing in Aspergillosis pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Aspergillosis pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. ASPERGILLOSIS PIPELINE MARKET INSIGHTS, 2020

1.1 Aspergillosis Disease Overview
1.2 Aspergillosis Drug Pipeline Snapshot, 2020
  1.2.1 Aspergillosis Pipeline Drugs by Phase
  1.2.2 Aspergillosis Pipeline Drugs by Company
  1.2.3 Aspergillosis Pipeline Drugs by Mechanism of Action
  1.2.4 Aspergillosis Pipeline Drugs by Route of Administration

2. ASPERGILLOSIS COMPANY WISE PIPELINE DETAILS

Acea Biotech Inc Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Amplyx Pharmaceuticals Inc Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Astellas Pharma Inc Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Basilea Pharmaceutica Ltd Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Biosergen AS Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Cidara Therapeutics Inc Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
F2G Ltd Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
iCo Therapeutics Inc. Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Matinas BioPharma Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Mayne Pharma Group Ltd Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Merck & Co Inc Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Molecular Express Inc Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Novabiotics Ltd Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Pulmatrix Inc Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Pulmocide Ltd Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Scynexis Inc Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Sealife PHARMA GMBH Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Shaanxi Synthetic Pharmaceutical Co Ltd Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Viamet Pharmaceuticals Inc Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vical Inc Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Visterra Inc Aspergillosis Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. ASPERGILLOSIS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. ASPERGILLOSIS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications